本页面由Tiger Trade Technology Pte. Ltd.提供服务

Olema Pharmaceuticals, Inc.

15.06
-0.0600-0.40%
盘后15.060.00000.00%16:10 EDT
成交量:90.44万
成交额:1,353.51万
市值:13.13亿
市盈率:-8.05
高:15.12
开:14.69
低:14.62
收:15.12
52周最高:36.26
52周最低:2.86
股本:8,715.70万
流通股本:7,188.81万
量比:0.83
换手率:1.26%
股息:- -
股息率:- -
每股收益(TTM):-1.8700
每股收益(LYR):-1.8700
净资产收益率:-36.61%
总资产收益率:-21.42%
市净率:2.74
市盈率(LYR):-8.05

数据加载中...

2023/06/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/05/11

重要事件披露

8-K - Current report
2023/05/09

重要事件披露

8-K - Current report
2023/05/09

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2023/04/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/03/29

关联方拟减持公告

144 - Report of proposed sale of securities
2023/03/22

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/03/10

重要事件披露

8-K - Current report
2023/03/09

重要事件披露

8-K - Current report
2023/03/09

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2023/03/09

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/02/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2023/02/06

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/16

重要事件披露

8-K - Current report
2022/11/14

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/11/08

重要事件披露

8-K - Current report